GlassScriptPhysician profile
Jonathan Bridges
NPI 1083744510
$16,031.94
in general payments reported to CMS, 2019-2025
26 companies · $2,631 in 2025
The $2,631 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $64.10 · 2021: $371 · 2022: $668 · 2023: $4,746 · 2024: $5,737 · 2025: $2,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,516 · Food and Beverage: $4,283 · Consulting Fee: $1,290 · Entertainment: $23.61 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,516.25 |
| Food and Beverage | $4,282.97 |
| Consulting Fee | $1,290.00 |
| Entertainment | $23.61 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,762.37 | 2022-2025 | Advisa Dr Mri Surescan, Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $3,612.00 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $3,011.44 | 2019-2023 | |
| Abbott Laboratories | $790.39 | 2019-2025 | Mitraclip, Esprit, Xience Skypoint |
| Medtronic Vascular, INC. | $429.91 | 2019 | |
| Shockwave Medical, INC | $389.30 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $269.55 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $244.75 | 2019-2023 | Camzyos |
| Bard Peripheral Vascular, INC. | $213.79 | 2023 | |
| Stryker Corporation | $175.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.94 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $110.43 | 2025 | |
| Inari Medical, INC. | $110.01 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $92.97 | 2019 | |
| Livanova USA, INC. | $92.90 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $87.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $85.84 | 2019 | |
| Cardiovascular Systems INC. | $84.17 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $79.80 | 2019 | |
| Abiomed | $53.65 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.00 | 2019 | |
| Pfizer INC. | $43.39 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $35.04 | 2019 | |
| Opsens INC. | $23.61 | 2023 | Optowire |
| Ekos Corporation | $23.40 | 2019 | |
| Asahi Intecc USA, INC. | $22.66 | 2025 | Asahi Peripheral Vascular Wires |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.